195 related articles for article (PubMed ID: 25667379)
1. Hyperkalemia develops in some thyroidectomized patients undergoing thyroid hormone withdrawal in preparation for radioactive iodine ablation for thyroid carcinoma.
Horie I; Ando T; Imaizumi M; Usa T; Kawakami A
Endocr Pract; 2015 May; 21(5):488-94. PubMed ID: 25667379
[TBL] [Abstract][Full Text] [Related]
2. RENAL FUNCTION AND PLASMA RENIN ACTIVITY AS POTENTIAL FACTORS CAUSING HYPERKALEMIA IN PATIENTS WITH THYROID CARCINOMA UNDERGOING THYROID HORMONE WITHDRAWAL FOR RADIOACTIVE IODINE THERAPY.
Niri T; Horie I; Ando T; Kawahara H; Ueda M; Eto M; Sako A; Ikeuchi Y; Nakao T; Nakashima Y; Shigeno R; Ito A; Nozaki A; Haraguchi A; Natsuda S; Sagara I; Akazawa S; Kamada A; Imaizumi M; Abiru N; Usa T; Kawakami A
Endocr Pract; 2020 Feb; 26(2):197-206. PubMed ID: 31652100
[No Abstract] [Full Text] [Related]
3. Risk factors for developing hyponatremia in thyroid cancer patients undergoing radioactive iodine therapy.
Lee JE; Kim SK; Han KH; Cho MO; Yun GY; Kim KH; Choi HY; Ryu YH; Ha SK; Park HC
PLoS One; 2014; 9(8):e106840. PubMed ID: 25170831
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma.
Shakir MK; Krook LS; Schraml FV; Hays JH; Clyde PW
Thyroid; 2008 Jul; 18(7):787-92. PubMed ID: 18631009
[TBL] [Abstract][Full Text] [Related]
5. Effects of thyroid hormone withdrawal on metabolic and cardiovascular parameters during radioactive iodine therapy in differentiated thyroid cancer.
An JH; Song KH; Kim DL; Kim SK
J Int Med Res; 2017 Feb; 45(1):38-50. PubMed ID: 27856930
[TBL] [Abstract][Full Text] [Related]
6. Severe hyponatremia following radioactive iodine therapy in patients with differentiated thyroid cancer.
Kim SK; Yun GY; Kim KH; Park SK; Choi HY; Ha SK; Park HC
Thyroid; 2014 Apr; 24(4):773-7. PubMed ID: 24093878
[TBL] [Abstract][Full Text] [Related]
7. Rapid rise in serum thyrotropin concentrations after thyroidectomy or withdrawal of suppressive thyroxine therapy in preparation for radioactive iodine administration to patients with differentiated thyroid cancer.
Serhal DI; Nasrallah MP; Arafah BM
J Clin Endocrinol Metab; 2004 Jul; 89(7):3285-9. PubMed ID: 15240604
[TBL] [Abstract][Full Text] [Related]
8. Serum potassium in stage 5 CKD patients on their first presentation in a dialysis service of a county hospital in western Romania.
Gluhovschi G; Mateş A; Gluhovschi C; Golea O; Gădălean F; Somai M; Ene I; Petrica L; Velciov S
Rom J Intern Med; 2014; 52(1):30-8. PubMed ID: 25000676
[TBL] [Abstract][Full Text] [Related]
9. Effect of preparation method for radioactive iodine therapy on serum electrolytes.
Takata N; Miyagawa M; Okada T; Kawaguchi N; Fujimoto Y; Kouchi Y; Tsuruoka S; Uwatsu K; Kido T
Jpn J Radiol; 2023 Nov; 41(11):1247-1254. PubMed ID: 37184818
[TBL] [Abstract][Full Text] [Related]
10. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
[TBL] [Abstract][Full Text] [Related]
11. Quality of life and effectiveness comparisons of thyroxine withdrawal, triiodothyronine withdrawal, and recombinant thyroid-stimulating hormone administration for low-dose radioiodine remnant ablation of differentiated thyroid carcinoma.
Lee J; Yun MJ; Nam KH; Chung WY; Soh EY; Park CS
Thyroid; 2010 Feb; 20(2):173-9. PubMed ID: 20151824
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and severity of hyponatremia and hypercreatininemia in short-term uncomplicated hypothyroidism.
Baajafer FS; Hammami MM; Mohamed GE
J Endocrinol Invest; 1999 Jan; 22(1):35-9. PubMed ID: 10090135
[TBL] [Abstract][Full Text] [Related]
13. Treatment with patiromer decreases aldosterone in patients with chronic kidney disease and hyperkalemia on renin-angiotensin system inhibitors.
Weir MR; Bakris GL; Gross C; Mayo MR; Garza D; Stasiv Y; Yuan J; Berman L; Williams GH
Kidney Int; 2016 Sep; 90(3):696-704. PubMed ID: 27350174
[TBL] [Abstract][Full Text] [Related]
14. Antihypertensive Medications and the Prevalence of Hyperkalemia in a Large Health System.
Chang AR; Sang Y; Leddy J; Yahya T; Kirchner HL; Inker LA; Matsushita K; Ballew SH; Coresh J; Grams ME
Hypertension; 2016 Jun; 67(6):1181-8. PubMed ID: 27067721
[TBL] [Abstract][Full Text] [Related]
15. Levothyroxine-induced serum free thyroxine response following radioactive iodine administration in patients thyroidectomized for differentiated thyroid cancer: A randomized controlled trial.
Marina M; Maglietta G; De Filpo G; Aloe R; Gnocchi C; Iezzi E; Caminiti C; Ceresini G
Endocrine; 2022 Aug; 77(2):340-348. PubMed ID: 35751777
[TBL] [Abstract][Full Text] [Related]
16. Preparation for radioactive iodine therapy is not a risk factor for the development of hyponatremia in thyroid cancer patients.
Kim J; Cho SG; Kang SR; Kwon SY; Cho DH; Cho JS; Song HC
Medicine (Baltimore); 2017 Feb; 96(5):e6004. PubMed ID: 28151897
[TBL] [Abstract][Full Text] [Related]
17. Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.
Bakris GL; Pitt B; Weir MR; Freeman MW; Mayo MR; Garza D; Stasiv Y; Zawadzki R; Berman L; Bushinsky DA;
JAMA; 2015 Jul; 314(2):151-61. PubMed ID: 26172895
[TBL] [Abstract][Full Text] [Related]
18. Analysis of factors causing hyperkalemia.
Takaichi K; Takemoto F; Ubara Y; Mori Y
Intern Med; 2007; 46(12):823-9. PubMed ID: 17575373
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality-of-life study in patients with carcinoma of the thyroid after thyroxine withdrawal for whole body scanning.
Chow SM; Au KH; Choy TS; Lee SH; Yeung NY; Leung A; Leung A; Leung HL; Shek CC; Law SC
Laryngoscope; 2006 Nov; 116(11):2060-6. PubMed ID: 17075410
[TBL] [Abstract][Full Text] [Related]
20. Short-term severe thyroid hormone deficiency does not influence sleep parameters.
Koehler C; Ginzkey C; Kleinsasser NH; Hagen R; Reiners C; Verburg FA
Sleep Breath; 2013 Mar; 17(1):253-8. PubMed ID: 22411172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
